Related Experiment Video
Updated: Jul 15, 2026

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
Published on: June 16, 2022
MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation
Sudarshana M Sharma1, Agnieszka Bronisz, Rong Hu
1Department of Molecular and Cellular Biochemistry and the Comprehensive Cancer Center, Ohio State University, Columbus, Ohio 43210, USA.
Abstract:
Transcription factors NFATc1, PU.1, and MITF collaborate to regulate specific genes in response to colony-stimulating factor-1 (CSF-1) and receptor activator of NF-kappaB ligand (RANKL) signaling during osteoclast differentiation. However, molecular details concerning timing and mechanism of specific events remain ill-defined. In bone marrow-derived precursors, CSF-1 alone promoted assembly of MITF-PU.1 complexes at osteoclast target gene promoters like cathepsin K and acid 5 phosphatase without increasing gene expression. The combination of RANKL and CSF-1 concurrently increased the levels of MAPK-phosphorylated forms of MITF, p38 MAPK, and SWI/SNF chromatin-remodeling complexes bound to these target promoters and markedly increased expression of the genes. NFATc1 was subsequently recruited to complexes at the promoters during terminal stages of osteoclast differentiation. Genetic analysis of Mitf and Pu.1 in mouse models supported the critical interaction of these genes in osteoclast differentiation. The results define MITF and PU.1 as nuclear effectors that integrate CSF-1/RANKL signals during osteoclast differentiation to initiate expression of target genes, whereas a complex that includes NFATc1 may act to maintain target gene expression in differentiated cells.
Insights
Transcription factors MITF and PU.1 initiate gene expression during osteoclast differentiation by integrating CSF-1/RANKL signals. NFATc1 involvement later helps maintain this expression in mature cells.
Area of Science:
- Cell Biology
- Molecular Biology
- Immunology
Background:
- Osteoclast differentiation is crucial for bone remodeling.
- Signaling pathways involving CSF-1 and RANKL are key regulators.
- The precise roles and timing of transcription factors like MITF, PU.1, and NFATc1 are not fully understood.
Purpose of the Study:
- To elucidate the molecular mechanisms and timing of transcription factor involvement in CSF-1 and RANKL signaling during osteoclast differentiation.
- To define the roles of MITF, PU.1, and NFATc1 in regulating target gene expression.
Main Methods:
- Utilized bone marrow-derived precursors.
- Investigated transcription factor complex assembly and gene promoter binding.
- Analyzed MAPK phosphorylation and chromatin remodeling complex recruitment.
- Employed genetic analysis in mouse models (Mitf and Pu.1).
Main Results:
- CSF-1 alone promoted MITF-PU.1 complex assembly at target promoters without inducing expression.
- Combined RANKL and CSF-1 increased MAPK-phosphorylated MITF, p38 MAPK, SWI/SNF complexes, and gene expression.
- NFATc1 was recruited later in differentiation to maintain gene expression.
- Genetic studies confirmed the essential roles of Mitf and Pu.1.
Conclusions:
- MITF and PU.1 act as early nuclear effectors integrating CSF-1/RANKL signals to initiate osteoclast target gene expression.
- NFATc1-containing complexes likely maintain target gene expression in terminally differentiated osteoclasts.
Related Concept Videos
TGF - β Signaling Pathway
MAPK Signaling Cascades
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Master Transcription Regulators
PI3K/mTOR/AKT Signaling Pathway
Osteoclasts in Bone Remodeling

